title: Breakthrough discoveries in drug delivery technologies: the next 30 years.
abstract: What if we could open the 2044 special issue of the Journal of Controlled Release? Which drug delivery technologies will have led the field? Which ones will have successfully reached the marketplace? In attempting to answer these questions, we selected a few recent technologies and concepts that could, in our opinion, play a crucial role in coming years. In each case, emblematic papers are cited to introduce and discuss the selected topic.
authors.affiliation: Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093 Zurich, Switzerland.
authors.forename: Davide
authors.initials: D
authors.lastname: Brambilla
authors.affiliation: Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093 Zurich, Switzerland.
authors.forename: Paola
authors.initials: P
authors.lastname: Luciani
authors.affiliation: Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Vladimir-Prelog-Weg 1-5/10, 8093 Zurich, Switzerland. Electronic address: jleroux@ethz.ch.
authors.forename: Jean-Christophe
authors.initials: JC
authors.lastname: Leroux
mesh_terms: D035843:Biomedical Research / Q000639:trends; D055252:Cell-Derived Microparticles; D003692:Delayed-Action Preparations; D016503:Drug Delivery Systems / Q000639:trends*; D005544:Forecasting; D006801:Humans; D053758:Nanoparticles; D050130:Oncolytic Virotherapy / Q000639:trends
chemical_list: D003692:Delayed-Action Preparations
keywords: Cell therapy; EPR effect; Microchips; Microneedles; Nanoparticles; Oncolytic viruses